Director Megan Cornish filed a Form 4 with the SEC on November 19, 2026, disclosing a purchase of Sensus Healthcare, Inc. common stock on November 18, 2026.

Key Highlights

  • Reporting person: Megan Cornish, identified as a Director of Sensus Healthcare, Inc. (NASDAQ:SRTS)
  • Transaction: Purchase (transaction code P) of 2,200 shares of common stock on November 18, 2026
  • Price paid: $2.28 per share
  • Resulting ownership: 34,200 shares of common stock beneficially owned directly following the transaction
  • Filing date: November 19, 2026, filed by one reporting person

Cornish Adds to Direct Holdings in Sensus Healthcare Common Stock

According to the Form 4 filing, Megan Cornish, a Director of Sensus Healthcare, Inc., acquired 2,200 shares of the company's common stock on November 18, 2026, at a price of $2.28 per share. The transaction is coded "P," indicating an open-market purchase. The filing reports no deemed execution date separate from the transaction date.

Following the reported transaction, the filing discloses that Cornish directly beneficially owns 34,200 shares of Sensus Healthcare common stock. The Form 4 covers only non-derivative securities; Table II, covering derivative securities such as options or warrants, reflects no transactions. The filing was signed by Megan Cornish and submitted to the SEC on November 19, 2026.

The filing does not indicate that the purchase was made pursuant to a Rule 10b5-1(c) plan, as the corresponding checkbox on the form was not selected. No amendment date is listed, indicating this is an original filing. Sensus Healthcare, Inc. trades on NASDAQ under the symbol SRTS.

What Was Disclosed

Director Megan Cornish reported a direct open-market purchase of 2,200 shares of Sensus Healthcare common stock at $2.28 per share on November 18, 2026, bringing her total direct beneficial ownership to 34,200 shares.